Overview
Targeted RNA drug company Undecimal Bio completed EUR 16 million in seed funding.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: €16M (Seed), Oct 14, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 14, 2026 | €16M ≈ $17.6M · Seed | 4BIO Capital, IQ Capital | 1 source Source ↗ |
Evidence Targeted RNA drug company Undecimal Bio raises EUR 16 million in seed fundingTargeted RNA drug company Undecimal Bio completed EUR 16 million in seed funding from 4BIO Capital, IQ Capital and others. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Oct 14, 2026 | — · Seed | 4BIO Capital, IQ Capital | 1 source Source ↗ |
Evidence Targeted RNA drug company Undecimal Bio raises EUR 16 million in seed fundingTargeted RNA drug company Undecimal Bio completed EUR 16 million in seed funding from 4BIO Capital, IQ Capital and others. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
靶向RNA药物公司 Undecimal Bio 完成1600万欧元种子轮融资。